Text Size

Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pediatrix Medical Group
ClinicalTrials.gov Identifier:
NCT01560936
First received: March 19, 2012
Last updated: May 13, 2013
Last verified: May 2013
History of Changes
  Purpose

The purpose of this study is to determine the contamination rate of the parents cell phone in a newborn intensive care setting and identify the types of bacteria contaminating the cell phone as well as evaluating the effectiveness of an antimicrobial gel in reducing the transmission of bacteria from the cell phone to the parents hands.


Condition
Bacterial Contamination Rate of the Cell Phones

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU and the Effectiveness of an Antimicrobial Gel in Reducing Transmission to the Hands

Further study details as provided by Pediatrix Medical Group:

Primary Outcome Measures:
  • Determine contamination rate of parents cellphone in the NICU and identify types of bacteria on cell phones while evaluating the effectiveness of antimicrobial gel in reducing the transmission of bacteria from cellphone to parents hands. [ Time Frame: contamination rate through bacterial swabs ] [ Designated as safety issue: No ]

Enrollment: 50
Study Start Date: June 2012
Study Completion Date: March 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   13 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Parent's that have a cell phone when visiting their child in the NICU.

Criteria

Inclusion Criteria:

  • Parents with a cell phone

Exclusion Criteria:

  • Parents that do not have a cell phone
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01560936

Locations
United States, Washington
Swedish Medical Center
Seattle, Washington, United States
Sponsors and Collaborators
Pediatrix Medical Group
Investigators
Principal Investigator: Michael Kamitsuka, MD Swedish Hospital and Medical Center
  More Information

No publications provided

Responsible Party: Pediatrix Medical Group
ClinicalTrials.gov Identifier: NCT01560936     History of Changes
Other Study ID Numbers: 3.0
Study First Received: March 19, 2012
Last Updated: May 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Pediatrix Medical Group:
bacterial contamination

ClinicalTrials.gov processed this record on May 23, 2013